Atherosclerosis Plus SCIE

國(guó)際簡(jiǎn)稱：ATHEROSCLEROSIS PLUS 參考譯名：動(dòng)脈粥樣硬化加

主要研究方向：PERIPHERAL VASCULAR DISEASE 非預(yù)警期刊審稿周期： 11 Weeks

《動(dòng)脈粥樣硬化加》(Atherosclerosis Plus)是一本由Elsevier出版的以PERIPHERAL VASCULAR DISEASE為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開(kāi)放期刊，近三年沒(méi)有被列入預(yù)警名單。

4區(qū) 中科院分區(qū)
Q3 JCR分區(qū)
18 年發(fā)文量
1.4 IF影響因子
開(kāi)放 是否OA
English 出版語(yǔ)言

The original research and review papers published in the journal Atherosclerosis Plus deeply explored several key aspects of atherosclerosis, a complex pathological process. First, the research emphasized the pathogenesis of atherosclerosis, including endothelial dysfunction, lipid metabolism disorder, inflammatory response and smooth muscle cell proliferation. These mechanisms work together to cause lipid deposition and plaque formation in the arterial wall.

Secondly, the paper discusses the genetic basis of atherosclerosis and points out that some genetic variations may increase the risk of individuals developing the disease. In addition, the study also involves a variety of risk factors, including dyslipidemia, hypertension, obesity and diabetes, which can exacerbate the process of atherosclerosis. Changes in lifestyle, such as smoking, unhealthy diet and lack of physical activity, have also been confirmed to be closely related to the development of atherosclerosis. These bad habits can lead to further damage to endothelial function and increase the risk of cardiovascular disease.

[ 查看全部 ]

投稿咨詢加急咨詢

Atherosclerosis Plus期刊信息

ISSN：2667-0895
出版語(yǔ)言：English
是否OA：開(kāi)放
E-ISSN：2667-0895
出版地區(qū)：Netherlands
是否預(yù)警：否
出版商：Elsevier
Gold OA文章占比：91.18%
研究類文章占比：100.00%

Atherosclerosis Plus CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

2.6

0.476

0.481

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Internal Medicine	Q3	93 / 167	44%
大類：Medicine 小類：Cardiology and Cardiovascular Medicine	Q3	223 / 387	42%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書(shū)籍章節(jié)和數(shù)據(jù)論文。